/HLNCF
HLNCF Stock - Haleon plc
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$4.93+0.71%
+$0.04 (+0.71%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.57
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.43
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HLNCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.89 – $4.98
TARGET (TP)$5.68
STOP LOSS$4.54
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.23
52W High$5.80
52W Low$4.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.23B | $11.30B | $10.86B | $9.54B | $9.89B |
| Gross Profit | $6.82B | $6.96B | $6.58B | $5.95B | $5.91B |
| Gross Margin | 60.7% | 61.6% | 60.6% | 62.3% | 59.7% |
| Operating Income | $2.21B | $2.00B | $1.82B | $1.64B | $1.60B |
| Net Income | $1.44B | $1.05B | $1.06B | $1.39B | $1.15B |
| Net Margin | 12.8% | 9.3% | 9.8% | 14.6% | 11.6% |
| EPS | $0.16 | $0.11 | $0.11 | $0.15 | $0.12 |
Company Overview
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HLNCFBeat Rate
25%
Last 8 quarters
Avg Surprise
-45.5%
EPS vs Estimate
Beats / Misses
2/6
Last 12 quarters
Latest EPS
$0.06
Q3 2025
EPS Surprise History
Q3 23
No data
Q1 24
-100.4%
$-0.00vs$0.12
Q2 24
+3.2%
$0.06vs$0.06
Q3 24
-63.0%
$0.04vs$0.11
Q4 24
No data
Q1 25
-71.2%
$0.03vs$0.11
Q2 25
No data
Q3 25
-51.0%
$0.06vs$0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q3 2025 | Jul 31, 2025 | $0.12 | $0.06 | -51.0% | ✗ MISS |
Q2 2025 | May 8, 2025 | — | $0.06 | — | — |
Q1 2025 | Feb 27, 2025 | $0.11 | $0.03 | -71.2% | ✗ MISS |
Q4 2024 | Oct 31, 2024 | — | $0.07 | — | — |
Q3 2024 | Aug 1, 2024 | $0.11 | $0.04 | -63.0% | ✗ MISS |
Q2 2024 | May 1, 2024 | $0.06 | $0.06 | +3.2% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $0.12 | $-0.00 | -100.4% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | — | $0.05 | — | — |
Q3 2023 | Aug 2, 2023 | $0.11 | $0.04 | -62.8% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | — | $0.05 | — | — |
Q1 2023 | Mar 2, 2023 | $5.00 | $3.37 | -32.6% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $4.76 | $5.43 | +14.1% | ✓ BEAT |
Q3 2022 | Sep 20, 2022 | — | $0.03 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.05 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.08 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.05 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HLNCF
What is HLNCF's current stock price?
Haleon plc (HLNCF) is currently trading at $4.93 per share. The stock has moved +0.71% today.
What is the analyst price target for HLNCF?
No analyst price targets are currently available for this stock.
What sector is Haleon plc in?
Haleon plc operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is HLNCF's market cap?
Haleon plc has a market capitalization of $43.95 billion, making it a large-cap company.
Does HLNCF pay dividends?
No, Haleon plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCHALF
Chalice Brands Ltd.
$0.00
Mkt Cap: $0.0B
DSKYF
Daiichi Sankyo Company, Limited
$21.26
Mkt Cap: $39.4B
DSNKY
Daiichi Sankyo Company, Limited
$21.15
Mkt Cap: $39.5B
HOCPF
HOYA Corporation
$148.86
Mkt Cap: $50.7B
IPSEY
Ipsen S.A.
$35.19
Mkt Cap: $46.5B
MKGAF
Merck KGaA
$141.25
Mkt Cap: $61.4B
MKKGY
Merck KGaA
$27.89
Mkt Cap: $60.6B
TKPHF
Takeda Pharmaceutical Company Limited
$29.35
Mkt Cap: $46.4B
WUXAY
WuXi AppTec Co., Ltd.
$13.21
Mkt Cap: $37.8B
WUXIF
WuXi AppTec Co., Ltd.
$13.60
Mkt Cap: $39.0B
Explore stocks similar to HLNCF for comparison